Hommes M J, Romijn J A, Endert E, Adriaanse R, Brabant G, Eeftinck Schattenkerk J K, Wiersinga W M, Sauerwein H P
Department of Endocrinology, University of Amsterdam, The Netherlands.
Metabolism. 1993 May;42(5):556-61. doi: 10.1016/0026-0495(93)90212-7.
Thyroid function and regulation were studied in 14 consecutive male outpatients with asymptomatic human immunodeficiency virus (HIV) infection (CDC II/III, n = 8) or AIDS (CDC IV, n = 6) who were free of concomitant infections and hepatic dysfunction, and in eight healthy, age- and weight-matched male controls. Blood was sampled every 10 minutes over 24 hours for measurement of thyrotropin (TSH). Thereafter, thyroid hormones and TSH responsiveness to thyrotropin-releasing hormone (TRH) were measured. Triiodothyronine (T3) and thyroxine (T4) did not differ between HIV-infected patients and controls, but HIV patients had lower thyroid hormone-binding index ([THBI] HIV patients, 1.01 +/- 0.02; controls, 1.11 +/- 0.03; P < .02), free thyroxine (FT4) index (94 +/- 3 v 110 +/- 4, P < .01), FT4 (11.8 +/- 0.4 v 14.3 +/- 0.4 pmol/L, P < .01), and reverse triiodothyronine (rT3) values (0.18 +/- 0.01 v 0.26 +/- 0.02 nmol/L, P < .001) and higher thyroxine-binding globulin ([TBG] 20 +/- 1 v 16 +/- 1 mg/L, P < .02) values. Mean 24-hour TSH levels were increased in HIV patients (2.39 +/- 0.33 v 1.44 +/- 0.16 mU/L, P < .05), associated with increased mean TSH pulse amplitude and TSH responsiveness to TRH. No differences were observed between asymptomatic HIV-seropositive and AIDS patients. In conclusion, there is a hypothyroid-like regulation of the pituitary-thyroid axis in stable HIV infection, which differs distinctly from the euthyroid sick syndrome in non-HIV-nonthyroidal illnesses.(ABSTRACT TRUNCATED AT 250 WORDS)
对14例连续的男性门诊患者的甲状腺功能及调节进行了研究,这些患者患有无症状人类免疫缺陷病毒(HIV)感染(疾病控制中心II/III级,n = 8)或艾滋病(疾病控制中心IV级,n = 6),且无合并感染及肝功能障碍,同时选取了8名年龄和体重匹配的健康男性作为对照。在24小时内每隔10分钟采集一次血液,用于测定促甲状腺激素(TSH)。此后,测定甲状腺激素以及TSH对促甲状腺激素释放激素(TRH)的反应性。HIV感染患者与对照组之间的三碘甲状腺原氨酸(T3)和甲状腺素(T4)无差异,但HIV患者的甲状腺激素结合指数较低([THBI] HIV患者为1.01±0.02;对照组为1.11±0.03;P <.02),游离甲状腺素(FT4)指数(94±3对110±4,P <.01)、FT4(11.8±0.4对14.3±0.4 pmol/L,P <.01)以及反三碘甲状腺原氨酸(rT3)值(0.18±0.01对0.26±0.02 nmol/L,P <.001)较低,而甲状腺素结合球蛋白([TBG] 20±1对16±1 mg/L,P <.02)值较高。HIV患者的24小时平均TSH水平升高(2.39±0.33对1.44±0.16 mU/L,P <.05),同时平均TSH脉冲幅度及TSH对TRH的反应性增加。无症状HIV血清阳性患者与艾滋病患者之间未观察到差异。总之,在稳定的HIV感染中存在垂体-甲状腺轴的甲状腺功能减退样调节,这与非HIV非甲状腺疾病中的正常甲状腺病态综合征明显不同。(摘要截取自250字)